[2-(BENZOTHIAZOL-2-YLSULFANYLMETHYL)PHENYL]METHOXYIMINOACETIC ACID METHYL ESTER


Molecule Category	Free-form
Source	Gaulton A, Kale N, van Westen GJ, Bellis LJ, Bento AP, Davies M, Hersey A, Papadatos G, Forster M, Wege P, Overington JP. A large-scale crop protection bioassay data set. Sci Data. 2015 Jul 7;2:150032. Read more ...


Active Pharmaceutical Ingredients Bioactive chemicals	Exact Similarity SubStructure	Threshold (%) >= 70

Structure


InChI Key	ZQPSIBHSYMCHKS-CAPFRKAQSA-N
Smiles	CO\N=C(\C(=O)OC)/c1ccccc1CSc2nc3ccccc3s2
InChI	InChI=1S/C18H16N2O3S2/c1-22-17(21)16(20-23-2)13-8-4-3-7-12(13)11-24-18-19-14-9-5-6-10-15(14)25-18/h3-10H,11H2,1-2H3/b20-16+

Physicochemical Descriptors

Property Name	Value
Molecular Formula	C18H16N2O3S2
Molecular Weight	372.46
AlogP	4.43
Hydrogen Bond Acceptor	6.0
Hydrogen Bond Donor	0.0
Number of Rotational Bond	7.0
Polar Surface Area	114.32
Molecular species	NEUTRAL
Aromatic Rings	3.0
Heavy Atoms	25.0

Assay Description	Organism	Bioactivity
Antifungal activity against Pseudoperonospora cubensis inoculated in inoculated in cucumber plant assessed as preventive fungicidal activity measured after 7 days	Pseudoperonospora cubensis	150.32 ug ml-1
Antifungal activity against Pseudoperonospora cubensis inoculated in inoculated in cucumber plant assessed as preventive fungicidal activity at 25 ug/mL measured after 7 days	Pseudoperonospora cubensis	39.0 %
Antifungal activity against Pseudoperonospora cubensis inoculated in inoculated in cucumber plant assessed as preventive fungicidal activity at 50 ug/mL measured after 7 days	Pseudoperonospora cubensis	66.0 %
Antifungal activity against Pseudoperonospora cubensis inoculated in inoculated in cucumber plant assessed as preventive fungicidal activity at 100 ug/mL measured after 7 days	Pseudoperonospora cubensis	84.0 %
Antifungal activity against Podosphaera fuliginea inoculated in inoculated in cucumber plant assessed as preventive fungicidal activity measured after 7 days	Podosphaera fuliginea	9.6 ug ml-1
Antifungal activity against Podosphaera fuliginea inoculated in inoculated in cucumber plant assessed as preventive fungicidal activity at 25 ug/mL measured after 7 days	Podosphaera fuliginea	97.0 %
Antifungal activity against Podosphaera fuliginea inoculated in inoculated in cucumber plant assessed as preventive fungicidal activity at 50 ug/mL measured after 7 days	Podosphaera fuliginea	100.0 %
Antifungal activity against Podosphaera fuliginea inoculated in inoculated in cucumber plant assessed as preventive fungicidal activity at 100 ug/mL measured after 7 days	Podosphaera fuliginea	100.0 %
Antifungal activity against Colletotrichum gossypii assessed as inhibition rate at 50 ug/mL	Colletotrichum gossypii	75.0 %
Antifungal activity against Dothiorella gregaria assessed as inhibition rate at 50 ug/mL	Dothiorella gregaria	84.0 %
Antifungal activity against Fusarium graminearum assessed as inhibition rate at 50 ug/mL	Fusarium graminearum	81.0 %
Antifungal activity against Rhizoctonia solani assessed as inhibition rate at 50 ug/mL	Rhizoctonia solani	82.0 %
Antifungal activity against Botrytis cinereapers assessed as inhibition rate at 50 ug/mL	Botrytis	52.0 %
Antifungal activity against Fusarium oxysporum assessed as inhibition rate at 50 ug/mL	Fusarium oxysporum	74.0 %

Cross References

Resources	Reference
ChEMBL	CHEMBL2251346
PubChem	16127030

CONTENTS


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).